claim
Soluble Urokinase Plasminogen Activator Receptor (suPAR) offers potential insights into conditions such as cancer, cardiovascular disease, kidney disease, and infections.
Authors
Sources
- Tracking Inflammation Through Biomarkers www.rupahealth.com via serper
Referenced by nodes (2)
- cancer concept
- cardiovascular disease concept